BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mahmoudi M, Pakpour S, Perry G. Drug-Abuse Nanotechnology: Opportunities and Challenges. ACS Chem Neurosci 2018;9:2288-98. [PMID: 29851334 DOI: 10.1021/acschemneuro.8b00127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ju L, Lyu A, Hao H, Shen W, Cui H. Deep Learning-Assisted Three-Dimensional Fluorescence Difference Spectroscopy for Identification and Semiquantification of Illicit Drugs in Biofluids. Anal Chem 2019;91:9343-7. [DOI: 10.1021/acs.analchem.9b01315] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Papadopoulos PD, Tsigalou C, Valsamaki PN, Konstantinidis TG, Voidarou C, Bezirtzoglou E. The Emerging Role of the Gut Microbiome in Cardiovascular Disease: Current Knowledge and Perspectives. Biomedicines 2022;10:948. [DOI: 10.3390/biomedicines10050948] [Reference Citation Analysis]
3 Kazemian N, Mahmoudi M, Halperin F, Wu JC, Pakpour S. Gut microbiota and cardiovascular disease: opportunities and challenges. Microbiome 2020;8:36. [PMID: 32169105 DOI: 10.1186/s40168-020-00821-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 26.0] [Reference Citation Analysis]